ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives.

With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers.

In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B is applicable to various CNS targets across a plethora of neurological disorders, potentially providing a breakthrough to address the high unmet medical needs in neurodegeneration. 

We continue to actively expand and advance our pipeline through global strategic partnerships. For more information, please visit http://ablbio.com

Life Sciences

Health Care

Biotechnology

ABL Bio Inc.

ABL Bio Inc.'s headquarters in Seongnam-si, Republic of Korea

Sang Hoon Lee

Yongsun Kwon

This department conducts scientific research and develops innovative products and solutions.

Research and Development

This department oversees the overall strategic direction and operational execution of the organization.

Executive Leadership

This department oversees the advancement of oncology research and the clinical development of related therapies.

Oncology Development

This department oversees the planning, execution, and completion of projects to ensure they meet organizational goals.

Project Management

This department conducts advanced research and development initiatives to innovate and improve products and processes.

ABL Bio Inc.

Org chart

Teams

Research and Development

Executive Leadership

Oncology Development

Project Management

Research Department

Offices

ABL Bio Inc.

Org chart

Teams

Research and Development

Executive Leadership

Oncology Development

Project Management

Research Department

Offices

Related companies